Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to 0.01.

  • Lifecore Biomedical, Inc. \De\'s Equity Ratio fell 8747.15% to 0.01 in Q2 2025 from the same period last year, while for May 2025 it was 0.01, marking a year-over-year decrease of 8747.15%. This contributed to the annual value of 0.01 for FY2025, which is 8747.15% down from last year.
  • Lifecore Biomedical, Inc. \De\'s Equity Ratio amounted to 0.01 in Q2 2025, which was down 8747.15% from 0.01 recorded in Q1 2025.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Equity Ratio peaked at 0.44 during Q1 2022, and registered a low of 0.06 during Q3 2023.
  • Moreover, its 5-year median value for Equity Ratio was 0.11 (2023), whereas its average is 0.18.
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Equity Ratio tumbled by 11888.42% in 2023, and later surged by 94645.21% in 2024.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Equity Ratio (Quarter) stood at 0.37 in 2021, then plummeted by 30.12% to 0.26 in 2022, then plummeted by 97.76% to 0.01 in 2023, then surged by 946.45% to 0.06 in 2024, then tumbled by 90.77% to 0.01 in 2025.
  • Its Equity Ratio stands at 0.01 for Q2 2025, versus 0.01 for Q1 2025 and 0.06 for Q4 2024.